BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cuadrado A, San Segundo D, López-Hoyos M, Crespo J, Fábrega E. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol 2015; 21(39): 11016-11026 [PMID: 26494958 DOI: 10.3748/wjg.v21.i39.11016]
URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11016.htm
Number Citing Articles
1
Claudia Mescoli, Laura Albertoni, Anthony Jake Demetris. Textbook of Liver Transplantation2022; : 319 doi: 10.1007/978-3-030-82930-8_18
2
C.M. Lin, R.J. Plenter, M. Coulombe, R.G. Gill. Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell–Mediated Antibody-dependent Chronic RejectionAmerican Journal of Transplantation 2016; 16(11): 3121 doi: 10.1111/ajt.13865
3
Bejan Sultani, Matthias Marget, Andrea Briem‐Richter, Jochen Herrmann, Sebastian Meisner, Enke Freya Grabhorn, Ann‐Kathrin Ozga, Sören Weidemann, Uta Herden, Lutz Fischer, Martina Sterneck. Presence of donor specific HLA class 2 antibodies (DSA class 2) is associated with development of graft fibrosis more than 10 years after liver transplantation–a retrospective single center studyClinical Transplantation 2021; 35(7) doi: 10.1111/ctr.14336
4
Manuel Muro, Isabel Legaz. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantationWorld Journal of Gastroenterology 2023; 29(5): 766-772 doi: 10.3748/wjg.v29.i5.766
5
Emma Monique Saelens, Stephanie Van Biervliet, Saskia Vande Velde, Myriam Van Winckel, Xavier Rogiers, Aude Vanlander, Liesbeth Daniëls, Carolien Bonroy, Ruth M.L. De Bruyne. Autoantibodies and Donor-specific Antibodies are Associated With Graft Dysfunction in Pediatric Liver TransplantationJournal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 661 doi: 10.1097/MPG.0000000000002913
6
Yi-Ping Jin, Nicole M. Valenzuela, Xiaohai Zhang, Enrique Rozengurt, Elaine F. Reed. HLA Class II–Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant RejectionThe Journal of Immunology 2018; 200(7): 2372 doi: 10.4049/jimmunol.1701259
7
M.-W. Welker, A. A. Schnitzbauer. Aktuelle Aspekte der Immunsuppression nach Transplantation solider OrganeDer Gastroenterologe 2019; 14(4): 289 doi: 10.1007/s11377-019-0357-y
8
Carme Baliellas, Laura Lladó, Teresa Serrano, Emma Gonzalez-Vilatarsana, Alba Cachero, Josefina Lopez-Dominguez, Anna Petit, Joan Fabregat. Sinusoidal obstruction syndrome as a manifestation of acute antibody-mediated rejection after liver transplantationAmerican Journal of Transplantation 2021; 21(11): 3775 doi: 10.1111/ajt.16689
9
Michelle Bräutigam, Thomas Volken, Alexandra Plattner, Jakob R. Passweg, Jörg P. Halter, Beatrice Drexler, Dominik Heim, Stefan Schaub, Andreas S. Buser, Laura Infanti, Andreas Holbro. Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantationTransfusion and Apheresis Science 2022; 61(2): 103301 doi: 10.1016/j.transci.2021.103301
10
Kenei Furukawa, Koichiro Haruki, Mureo Kasahara, Tomohiko Taniai, Toru Ikegami. Dual Antibody Treatment for Simultaneous Acute Cellular Rejection and Antibody-Mediated Rejection After Liver Transplantation: A Case ReportTransplantation Proceedings 2023; 55(8): 1938 doi: 10.1016/j.transproceed.2023.03.093
11
Dominique Schluckebier, Vladimir L. Cousin, Laetitia‐Marie Petit, Dominique Belli, Barbara Wildhaber, Anne‐Laure Rougemont, Jean Villard, Sylvie Ferrari‐Lacraz, Valérie A. McLin. Preformed and de novo DSA are associated with T‐cell–mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsyPediatric Transplantation 2020; 24(1) doi: 10.1111/petr.13611
12
Nobuhisa Akamatsu, Kiyoshi Hasegawa, Seisuke Sakamoto, Hideki Ohdan, Ken Nakagawa, Hiroto Egawa. Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide SurveyTransplantation Direct 2021; 7(8): e729 doi: 10.1097/TXD.0000000000001180
13
Vadim Jucaud, Abraham Shaked, Michele DesMarais, Peter Sayre, Sandy Feng, Josh Levitsky, Matthew J. Everly. Prevalence and Impact of De Novo Donor‐Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant RecipientsHepatology 2019; 69(3): 1273 doi: 10.1002/hep.30281
14
Jérôme Dumortier, Filomena Conti, Jean-Baptiste Hiriart, Sébastien Dharancy, Christophe Duvoux, Camille Besch, Pauline Houssel-Debry, Marianne Latournerie, Faiza Chermak, Magdalena Meszaros, Georges-Philippe Pageaux, Sylvie Radenne, Olivier Boillot, Jean Hardwigsen, Ilias Kounis, Nassim Kamar, Faouzi Saliba, Domitille Erard, Arnaud Del Bello. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective studyLiver Transplantation 2023; 29(12): 1313 doi: 10.1097/LVT.0000000000000200
15
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantationPortal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
16
Zahra Beyzaei, Bita Geramizadeh, Zahra Bagheri, Sara Karimzadeh, Alireza Shojazadeh. De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-AnalysisFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.613128
17
Martin-Walter Welker, Andreas A. A. Schnitzbauer. Aktuelle Aspekte der Immunsuppression nach Transplantation solider OrganeWiener klinisches Magazin 2019; 22(6): 272 doi: 10.1007/s00740-019-00315-2
18
Yoshihiro Hirata, Atsushi Yoshizawa, Hiroto Egawa, Daisuke Ueda, Shinya Okamoto, Hideaki Okajima, Kimiko Yurugi, Rie Hishida, Hideyo Hirai, Aya Miyagawa-Hayashino, Taira Maekawa, Hironori Haga, Sinji Uemoto. Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation HepatitisTransplantation 2017; 101(5): 1074 doi: 10.1097/TP.0000000000001653
19
Henry Sutanto, Ummi Maimunah, Deasy Fetarayani. Donor-specific antibodies and their impact on antibody-mediated rejection post-liver transplantation: A comprehensive reviewJournal of Liver Transplantation 2024; 14: 100214 doi: 10.1016/j.liver.2024.100214
20
Jennifer A. McCaughan, Victoria Robertson, Stuart J. Falconer, Claire Cryer, David M. Turner, Gabriel C. Oniscu. Preformed donor‐specific HLA antibodies are associated with increased risk of early mortality after liver transplantationClinical Transplantation 2016; 30(12): 1538 doi: 10.1111/ctr.12851
21
Anna Mariani, Matteo Tripepi, Iacopo Mangoni, Paolo Aseni. The High-risk Surgical Patient2023; : 551 doi: 10.1007/978-3-031-17273-1_50
22
Andrew D. Clouston, Stefan G. Hübscher. MacSween's Pathology of the Liver2024; : 947 doi: 10.1016/B978-0-7020-8228-3.00014-4
23
Andrew D. Clouston, Stefan G. Hübscher. Macsween's Pathology of the Liver2018; : 880 doi: 10.1016/B978-0-7020-6697-9.00014-5
24
Manuel Arias, Daniel Serón, Ignacio Herrero, David N. Rush, Chris Wiebe, Peter W. Nickerson, Piedad Ussetti, Emilio Rodrigo, Maria-Angeles de Cos. Subclinical Antibody-Mediated RejectionTransplantation 2017; 101(6S): S1 doi: 10.1097/TP.0000000000001735
25
Manuel Muro. The endless history or search for the true role of alloantibodies in liver transplantationClinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101544 doi: 10.1016/j.clinre.2020.09.005
26
Nicole M. Valenzuela, Michelle J. Hickey, Elaine F. Reed. Antibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationFrontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00433
27
Hyeyoung Kim, Nam‐Joon Yi, Eun Young Song, Kyoungbun Lee, Kwang‐Woong Lee, Hae Won Lee, Hye Young Ahn, Kyung Chul Yoon, Suk Kyun Hong, Kyung‐Suk Suh. Preformed donor‐specific antibodies do not affect the 1‐year allograft survival in living donor liver transplantationClinical Transplantation 2018; 32(5) doi: 10.1111/ctr.13244
28
D. San Segundo, C. Alonso, P. Ruiz, I. Roman, M.T. Arias-Loste, A. Cuadrado, A. Puente, F. Casafont, M. López-Hoyos, J. Crespo, E. Fábrega. De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver TransplantationTransplantation Proceedings 2016; 48(9): 2980 doi: 10.1016/j.transproceed.2016.08.037
29
Taichi Arai, Hideyo Oguchi, Kazunobu Shinoda, Kei Sakurabayashi, Tetuo Mikami, Yoshihiro Itabashi, Ken Sakai. Clinicopathological Analysis of Acute/Active Antibody-Mediated Rejection in Renal Allografts According to the Banff 2013 ClassificationNephron 2020; 144(Suppl. 1): 18 doi: 10.1159/000512143
30
Jin Wang, Ping Wang, Shuiliang Wang, Jianming Tan. Donor-specific HLA Antibodies in Solid Organ Transplantation: Clinical Relevance and DebatesExploratory Research and Hypothesis in Medicine 2019; 0(000): 1 doi: 10.14218/ERHM.2019.00012
31
Savio G. Barreto, Mark E. Brooke-Smith, Eu Ling Neo, Paul Dolan, Richard Leibbrandt, Tim Emery, Robert Carroll, Alan Wigg, John W. Chen. Exploring pre-surgery donor-specific antibodies in the context of organ shortage in liver transplantLangenbeck's Archives of Surgery 2019; 404(7): 865 doi: 10.1007/s00423-019-01831-9
32
Yuanyi Mang, Yang Gao, Yan Yang, Mei Dong, Qian Yang, Hong Li, Jianghua Ran, Li Li, Jun Ma, Guoyu Chen, Bin Yang, Ying Xie, Yunsong Wu, Yingpeng Zhao, Shengning Zhang. Experience on AMR Diagnosis and Treatment Following Liver Transplantation: Case SeriesTransplantation Direct 2024; 10(4): e1598 doi: 10.1097/TXD.0000000000001598
33
Ming-Li Yin, Hong-Li Song, Yang Yang, Wei-Ping Zheng, Tao Liu, Zhong-Yang Shen. Effect of <i>CXCR3/HO-1</i> genes modified bone marrow mesenchymal stem cells on small bowel transplant rejectionWorld Journal of Gastroenterology 2017; 23(22): 4016-4038 doi: 10.3748/wjg.v23.i22.4016